Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86


Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells.

Davis FM, Kenny PA, Soo ET, van Denderen BJ, Thompson EW, Cabot PJ, Parat MO, Roberts-Thomson SJ, Monteith GR.

PLoS One. 2011;6(8):e23464. doi: 10.1371/journal.pone.0023464. Epub 2011 Aug 5.


Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Azimi I, Beilby H, Davis FM, Marcial DL, Kenny PA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Mol Oncol. 2016 Jan;10(1):166-78. doi: 10.1016/j.molonc.2015.09.006. Epub 2015 Sep 25.


Non-stimulated, agonist-stimulated and store-operated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry.

Davis FM, Peters AA, Grice DM, Cabot PJ, Parat MO, Roberts-Thomson SJ, Monteith GR.

PLoS One. 2012;7(5):e36923. doi: 10.1371/journal.pone.0036923. Epub 2012 May 30.


Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.

Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney JW Jr, Goodhill GJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Oncogene. 2014 May 1;33(18):2307-16. doi: 10.1038/onc.2013.187. Epub 2013 May 20.


Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.

Cursons J, Leuchowius KJ, Waltham M, Tomaskovic-Crook E, Foroutan M, Bracken CP, Redfern A, Crampin EJ, Street I, Davis MJ, Thompson EW.

Cell Commun Signal. 2015 May 15;13:26. doi: 10.1186/s12964-015-0106-x.


Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.

Stewart TA, Azimi I, Brooks AJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Int J Biochem Cell Biol. 2016 Jul;76:64-74. doi: 10.1016/j.biocel.2016.05.007. Epub 2016 May 7.


Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.

Tsai PC, Fu YS, Chang LS, Lin SR.

Toxicon. 2016 Mar 1;111:108-20. doi: 10.1016/j.toxicon.2016.01.051. Epub 2016 Jan 14.


A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.

Stewart TA, Azimi I, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):509-14. doi: 10.1016/j.bbrc.2015.01.141. Epub 2015 Feb 7.


Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line.

Davis FM, Parsonage MT, Cabot PJ, Parat MO, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Cancer Cell Int. 2013 Jul 29;13(1):76. doi: 10.1186/1475-2867-13-76.


Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.

Wendt MK, Smith JA, Schiemann WP.

Oncogene. 2010 Dec 9;29(49):6485-98. doi: 10.1038/onc.2010.377. Epub 2010 Aug 30.


Specific N-glycan alterations are coupled in epithelial-mesenchymal transition induced by EGF in GE11 epithelial cells.

Xu Q, Qu C, Wang W, Gu J, Du Y, Song L.

Cell Biol Int. 2017 Feb;41(2):124-133. doi: 10.1002/cbin.10707. Epub 2016 Dec 29.


Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.

Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.

Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.


Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.

Vergara D, Valente CM, Tinelli A, Siciliano C, Lorusso V, Acierno R, Giovinazzo G, Santino A, Storelli C, Maffia M.

Cancer Lett. 2011 Nov 1;310(1):1-8. doi: 10.1016/j.canlet.2011.04.009. Epub 2011 Jun 24.


Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.

Liu ZC, Chen XH, Song HX, Wang HS, Zhang G, Wang H, Chen DY, Fang R, Liu H, Cai SH, Du J.

Cell Tissue Res. 2014 Nov;358(2):491-502. doi: 10.1007/s00441-014-1953-2. Epub 2014 Aug 16.


Increase of intracellular Ca2+ by purinergic receptors in cultured rat lacrimal gland myoepithelial cells.

Ohtomo K, Shatos MA, Vrouvlianis J, Li D, Hodges RR, Dartt DA.

Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9503-15. doi: 10.1167/iovs.11-7809.


Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.

Resende RR, Britto LR, Ulrich H.

Int J Dev Neurosci. 2008 Nov;26(7):763-77. doi: 10.1016/j.ijdevneu.2008.07.008. Epub 2008 Jul 18.


Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.

Bocca C, Bozzo F, Cannito S, Parola M, Miglietta A.

Mol Carcinog. 2012 Oct;51(10):783-95. doi: 10.1002/mc.20846. Epub 2011 Aug 31.


MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.

Xue L, Su D, Li D, Gao W, Yuan R, Pang W.

Cell Biochem Biophys. 2015 May;72(1):185-90. doi: 10.1007/s12013-014-0435-1.


Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.

Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, Uesugi M, Agoulnik S, Taylor N, Funahashi Y, Matsui J.

Br J Cancer. 2014 Mar 18;110(6):1497-505. doi: 10.1038/bjc.2014.80. Epub 2014 Feb 25.

Supplemental Content

Support Center